Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome

Hepato-Gastroenterology

Volumn 49, Issue 47, 2002, Pages 1195-1200

  Günsar, Fulya ^a   Akarca, Ulus Salih ^a   Ersöz, Galip ^a   Karasu, Zeki ^a   Yüce, Gül ^a   Batur, Yücel ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Autoimmune hepatitis overlap syndrome; Primary biliary cirrhosis; Ursodeoxycholic acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLOBULIN; IMMUNOGLOBULIN; PREDNISOLONE; PROTEIN; URSODEOXYCHOLIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; BIOCHEMISTRY; BIOPSY; CHEMICAL ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; DRUG RESPONSE; FATIGUE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIMARY BILIARY CIRRHOSIS AUTOIMMUNE HEPATITIS OVERLAP SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PRURITUS; SYMPTOM;

ADULT; AGED; CHOLAGOGUES AND CHOLERETICS; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER; LIVER CIRRHOSIS, BILIARY; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PREDNISOLONE; SYNDROME; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 0036377947     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy
2. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: Evidence for it being a hepatitic form of PBC in genetically susceptible individuals
3. The variant forms of autoimmune hepatitis
4. Recent developments in autoimmune liver diseases
5. Natural history, clinical features, and treatment of autoimmune hepatitis
6. Autoimmune chronic active hepatitis - A spesific entity? The negative argument
7. Autoimmune liver disease
8. Primary biliary cirrhosis
9. Ursodeoxycholic therapy in chronic liver disease: A metaanalysis in primary biliary cirrhosis and in chronic hepatitis
10. A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: Hepatic improvement but greater bone loss
11. Staging of chronic non-suppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
12. An algorithm for the grading of activity in chronic hepatitis C
13. Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis
14. Cholestasis in active chronic hepatitis
15. Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients
16. Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndrome
17. Biochemical features of acute and chronic hepatitis
18. Serological classification of chronic cholestatic liver diseases by the use of two different types of antimitochondrial antibodies
19. Ten year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis
20. Chronic cholestatic diseases
21. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis
22. Ursodiol for the long term treatment of primary biliary cirrhosis
23. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis
24. A randomized, double-blind, placebo-controlled trial of ursodeoxycholate in primary biliary cirrhosis
25. Histopathological study of primary biliary cirrhosis and effect of ursodeoxycholic acid treatment on histology progression
26. Treatment of primary biliary cirrhosis